Rivernorth Capital Management’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25	Closed	-$505K	–	757
2022 Q3	$505K	Hold	25	–	–	0.02%	464
2022 Q2	$501K	Hold	25	–	–	0.02%	449
2022 Q1	$500K	Hold	25	–	–	0.02%	462
2021 Q4	$496K	Buy	+25	New	+$496K	0.02%	403